| 1 |
Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth
Rajesh Ramasamy, Eric W.‐F. Lam, Inês Soeiro et al. · Leukemia
Open access |
14 Dec 2006 |
409 |
| 2 |
Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.
Naoto Itoh, Toshiaki Hanafusa, Atsushi Miyazaki et al. · Journal of Clinical Investigation
Open access |
Nov 1993 |
350 |
| 3 |
Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia
ZiYi Lim, Ronald Brand, Rodrigo Martino et al. · Journal of Clinical Oncology
Open access |
15 Dec 2009 |
305 |
| 4 |
The Structure and Pharmacological Functions of Coumarins and Their Derivatives
Lin Wu, Xiaohong Wang, Xu Wei et al. · Current Medicinal Chemistry
|
10 Oct 2009 |
289 |
| 5 |
Variations in the FTO gene are associated with severe obesity in the Japanese
Kikuko Hotta et al. · Journal of Human Genetics
Open access |
31 Mar 2008 |
246 |
| 6 |
Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)
Shinji Atagi, Masaaki Kawahara, Akira Yokoyama et al. · The Lancet Oncology
|
22 May 2012 |
240 |
| 7 |
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes
Arjan A. van de Loosdrecht et al. · Haematologica
Open access |
22 Jun 2009 |
239 |
| 8 |
Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial
Giorgio V. Scagliotti et al. · The Lancet Respiratory Medicine
|
15 May 2019 |
167 |
| 9 |
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis
Atsushi Hiraoka et al. · Cancer Medicine
Open access |
24 May 2019 |
159 |
| 10 |
Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection
Kentaro Matsuura et al. · Gastroenterology
Open access |
3 Feb 2017 |
156 |
| 11 |
Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor
Clemens L. Bockmeyer, Ralf Alexander Claus, Ulrich Budde et al. · Haematologica
Open access |
31 Dec 2007 |
148 |
| 12 |
A new method for in vitro expansion of cytotoxic human CD3−CD56+ natural killer cells
Stefan Carlens, Mari Gilljam, Benedict J. Chambers et al. · Human Immunology
|
Oct 2001 |
143 |
| 13 |
Association between obesity and polymorphisms in SEC16B, TMEM18, GNPDA2, BDNF, FAIM2 and MC4R in a Japanese population
Kikuko Hotta et al. · Journal of Human Genetics
|
23 Oct 2009 |
143 |
| 14 |
Two decades of annual medical examinations in Japanese obese children: Do obese children grow into obese adults?
Kazuaki Kotani, M. Nishida, Shizuya Yamashita et al. · International Journal of Obesity
|
Oct 1997 |
143 |
| 15 |
Protective Effects of Capsaicin against Cisplatin-Induced Nephrotoxicity in Rats
Yuka Shimeda, Yoshihiko Hirotani, Youko Akimoto et al. · Biological and Pharmaceutical Bulletin
Open access |
2005 |
139 |
| 16 |
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population
Andrea Casadei Gardini et al. · European Journal of Cancer
Open access |
25 Nov 2022 |
135 |
| 17 |
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis
Margherita Rimini et al. · ESMO Open
Open access |
5 Oct 2022 |
132 |
| 18 |
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis
Atsushi Hiraoka et al. · Cancer Medicine
Open access |
21 Dec 2018 |
132 |
| 19 |
Morphological evaluation of monocytes and their precursors
Jean-Etienne Goasguen, John M. Bennett, Barbara Jane Bain et al. · Haematologica
Open access |
16 Jun 2009 |
130 |
| 20 |
Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma
Yoshikazu Morimoto, Yasuhiro Tanaka, Toshinori Ito et al. · Journal of Hepato-Biliary-Pancreatic Surgery
|
Dec 2003 |
128 |
| 21 |
Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
Hirohisa Saito, Hirohisa Yoshizawa, Kozo Yoshimori et al. · Annals of Oncology
Open access |
2 Nov 2012 |
119 |
| 22 |
Resistive index predicts renal prognosis in chronic kidney disease
Takashi Sugiura, Akira Wada · Nephrology Dialysis Transplantation
|
23 Mar 2009 |
115 |
| 23 |
Follicular Lymphoma Cells Induce Changes in T-Cell Gene Expression and Function: Potential Impact on Survival and Risk of Transformation
Shahryar Kiaii, Andrew James Clear, Alan G. Ramsay et al. · Journal of Clinical Oncology
Open access |
17 Jun 2013 |
112 |
| 24 |
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease
Giovanni Pizzolo, Marco Chilosi, Fabrizio Vinante et al. · British Journal of Cancer
Open access |
Apr 1987 |
112 |
| 25 |
Low‐frequency subthalamic nucleus stimulation in Parkinson's disease: A randomized clinical trial
Hui Ming Khoo, Haruhiko Kishima, Koichi Hosomi et al. · Movement Disorders
|
21 Jan 2014 |
106 |
| 26 |
The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin’s and non-Hodgkin’s lymphoma survivors: a systematic review
Simone Oerlemans, Floortje Mols, Marten R. Nijziel et al. · Annals of Hematology
ReviewOpen access |
13 Jun 2011 |
100 |
| 27 |
4G/5G Polymorphism of PAI-1 Gene Promoter and Fibrinolytic Capacity in Patients with Deep Vein Thrombosis
Maria Teresa Sartori, Björn Wiman, Silvia Vettore et al. · Thrombosis and Haemostasis
|
1998 |
99 |
| 28 |
Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study
The Japan Adult Leukemia Study Group et al. · International Journal of Hematology
|
19 Sep 2017 |
98 |
| 29 |
Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib
Toshifumi Tada et al. · Liver International
Open access |
17 Feb 2020 |
97 |
| 30 |
Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population
Mayumi Kasahara, Kayo Osawa, Kana Yoshida et al. · Journal of Experimental & Clinical Cancer Research
Open access |
30 Sep 2008 |
94 |
| 31 |
Comparison of performances of artificial intelligence versus expert endoscopists for real-time assisted diagnosis of esophageal squamous cell carcinoma (with video)
Hiromu Fukuda, Ryu Ishihara, Yusuke Kato et al. · Gastrointestinal Endoscopy
Open access |
4 Jun 2020 |
92 |
| 32 |
Cortical excitability changes after high-frequency repetitive transcranial magnetic stimulation for central poststroke pain
Koichi Hosomi, Haruhiko Kishima, Satoru Oshino et al. · Pain
|
16 Apr 2013 |
91 |
| 33 |
Association of Epicardial, Visceral, and Subcutaneous Fat With Cardiometabolic Diseases
Fumi Sato, Norikazu Maeda, Takayuki Yamada et al. · Circulation Journal
Open access |
26 Sep 2017 |
90 |
| 34 |
Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF-κB Activation and De novo Gene Transcription
Andrea G.S. Buggins, Chris J. Pepper, Piers Patten et al. · Cancer Research
|
24 Aug 2010 |
89 |
| 35 |
Effect of Surgical Removal on Survival and Quality of Life in Patients With Supratentorial Glioblastoma
Yukitaka Ushio, Masato Kochi, Jun-ichiro Hamada et al. · Neurologia medico-chirurgica
Open access |
2005 |
88 |
| 36 |
Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer
Junichi Hasegawa, Junichi Nishimura, Tsunekazu Mizushima et al. · Cancer Chemotherapy and Pharmacology
|
4 Mar 2014 |
87 |
| 37 |
Increased error-prone NHEJ activity in myeloid leukemias is associated with DNA damage at sites that recruit key nonhomologous end-joining proteins.
Nicola Brady, Terry J. Gaymes, Manyee Cheung et al. · PubMed
|
15 Apr 2003 |
85 |
| 38 |
The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation
Pia Raanani, Francesco Dazzi, Jastinder Sohal et al. · British Journal of Haematology
Open access |
Dec 1997 |
85 |
| 39 |
Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study
Takeshi Hatanaka et al. · Hepatology International
|
24 Jun 2022 |
84 |
| 40 |
Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma
Atsushi Hiraoka et al. · Oncology
|
2019 |
83 |
| 41 |
Novel TET2 Mutations Associated With UPD4q24 in Myelodysplastic Syndrome
Azim M. Mohamedali, Alexander Smith, Joop A. Gäken et al. · Journal of Clinical Oncology
|
16 Jun 2009 |
82 |
| 42 |
Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice
Takaaki Tanaka et al. · Hepatology Research
Open access |
28 May 2022 |
79 |
| 43 |
Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population
Kikuko Hotta et al. · Journal of Human Genetics
Open access |
28 Jul 2011 |
76 |
| 44 |
Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma
Ayuko Saeki, Shinji Tamura, Nobuyuki Ito et al. · Cancer
|
28 Mar 2002 |
76 |
| 45 |
Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors
Frits van Rhee, David G. Savage, Jillian Blackwell et al. · Bone Marrow Transplantation
Open access |
May 1998 |
75 |
| 46 |
Subthalamic nucleus deep brain stimulation for camptocormia associated with Parkinson's disease
Wataru Sako, Masami Nishio, Tomoyuki Maruo et al. · Movement Disorders
|
7 Apr 2009 |
75 |
| 47 |
Multicenter, phase II, placebo‐controlled, double‐blind, randomized study of aprepitant in Japanese patients receiving high‐dose cisplatin
Toshiaki Takahashi, Eishin Hoshi, Masakazu Takagi et al. · Cancer Science
Open access |
24 Jul 2010 |
73 |
| 48 |
Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis
Yoshihiro Kamada et al. · PLoS ONE
Open access |
21 Jun 2013 |
73 |
| 49 |
Rapid Evolution of Yeast Centromeres in the Absence of Drive
Douda Bensasson, Magdalena Zarowiecki, Austin Burt et al. · Genetics
Open access |
Apr 2008 |
71 |
| 50 |
Bilateral pallidal deep brain stimulation in primary Meige syndrome
Wataru Sako, Ryoma Morigaki, Yoshifumi Mizobuchi et al. · Parkinsonism & Related Disorders
|
14 Dec 2010 |
71 |